RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

RF Safe argues that the established term “electromagnetic hypersensitivity” (EHS) should not be replaced by the newer label “EMR Syndrome,” claiming the rebranding fragments research and weakens advocacy. The piece frames EHS as a continuity-based concept tied to reported symptoms in EMF-rich environments and emphasizes practical mitigation via engineering, architecture, and policy—especially to reduce children’s exposure. It uses “EMR Syndrome” narrowly to describe what it portrays as an ideological, anti-technology pattern that blocks solutions rather than a physiological condition.

RF Safe publishes a commentary describing a public feud between Dr. Jack Kruse and RF Safe founder John Coates over how to address health concerns attributed to non-native electromagnetic fields (nnEMFs), especially regarding children. The piece portrays Kruse as emphasizing personal “light/circadian” biohacks and Coates as pushing technology and policy changes such as LiFi adoption and repealing/altering telecom-related legal constraints. It includes numerous claims about EMF-related harms and references to research (e.g., NTP/Ramazzini, a Henry Lai meta-analysis) but presents them within an advocacy narrative rather than as a balanced review.

This study reports on 26 adults self-diagnosed with electromagnetic hypersensitivity (EHS) who provided skin biopsies to generate primary fibroblast lines. The authors describe two EHS subsets based on questionnaire and DNA damage-related measures, and report delayed ATM nucleoshuttling after X-ray exposure in all samples, interpreted as impaired DNA repair signaling. They propose a molecular model linking EHS to ATM pathway dysfunction and suggest this could relate to increased cancer risk or accelerated aging.